코로나19 신약재창출 연구 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "코로나19 신약재창출 연구" in Korean language version.

refsWebsite

Global rank Korean rank

13doi.org

2^nd place

3^rd place

11nih.gov

4^th place

5clinicaltrials.gov

5,225^th place

4,327^th place

3worldcat.org

5^th place

11^th place

2theguardian.com

12^th place

65^th place

2fda.gov

447^th place

433^rd place

2plos.org

2,112^th place

1,114^th place

2biorxiv.org

5,061^st place

2,085^th place

1nature.com

234^th place

148^th place

1fox5ny.com

low place

1cdc.gov

218^th place

52^nd place

1miamiherald.com

752^nd place

2,233^rd place

1independent.co.uk

36^th place

175^th place

1technologyreview.com

1,943^rd place

1,161^st place

1ilfattoquotidiano.it

823^rd place

low place

1cnbc.com

220^th place

358^th place

1webmd.com

1,169^th place

735^th place

1coloradosun.com

low place

1who.int

195^th place

98^th place

1cell.com

2,814^th place

2,861^st place

biorxiv.org

Lane, Thomas R.; Dyall, Julie; Mercer, Luke; Goodin, Caleb; Foil, Daniel H.; Zhou, Huanying; Postnikova, Elena; Liang, Janie Y.; Holbrook, Michael R. (2020년 4월 27일). “Repurposing Pyramax® for the Treatment of Ebola Virus Disease: Additivity of the Lysosomotropic Pyronaridine and Non-Lysosomotropic Artesunate”. 《bioRxiv》 (영어): 2020.04.25.061333. doi:10.1101/2020.04.25.061333.
Bae, Joon-Yong; Lee, Gee Eun; Park, Heedo; Cho, Juyoung; Kim, Yung-Eui; Lee, Joo-Yeon; Ju, Chung; Kim, Won-Ki; Kim, Jin Il (2020년 7월 28일). “Pyronaridine and artesunate are potential antiviral drugs against COVID-19 and influenza”. 《bioRxiv》 (영어): 2020.07.28.225102. doi:10.1101/2020.07.28.225102.

cdc.gov

“Information for clinicians on therapeutic options for COVID-19 patients”. US Centers for Disease Control and Prevention. 2020년 3월 21일. 2020년 3월 22일에 확인함.

cell.com

Krishna, Sanjeev; Augustin, Yolanda; Wang, Jigang; Xu, Chengchao; Staines, Henry M.; Platteeuw, Hans; Kamarulzaman, Adeeba; Sall, Amadou; Kremsner, Peter (2021년 1월 19일). “Repurposing Antimalarials to Tackle the COVID-19 Pandemic: (Trends in Parasitology 37, 8–11; 2021)”. 《Trends in Parasitology》 (영어) 0 (0). doi:10.1016/j.pt.2020.12.009. ISSN 1471-4922.

clinicaltrials.gov

Clinical trial number NCT04332991 for "Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID)" - ClinicalTrials.gov
Shin Poong Pharmaceutical Co. Ltd. (2020년 12월 28일). “A Multi-center, Randomized, Double-blind, Parallel, Placebo-Controlled, Phase Ⅱ Clinical Trial to Evaluate Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients”.
“COVID-19 Treatment in South Africa - Full Text View - ClinicalTrials.gov” (영어). 2021년 1월 28일에 확인함.
“Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso - Full Text View - ClinicalTrials.gov” (영어). 2021년 1월 28일에 확인함.
Shin Poong Pharmaceutical Co. Ltd. (2021년 1월 17일). “A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 2/3 Clinical Trial to Evaluate the Safety and Efficacy of Pyronaridine-artesunate (Artecom®) in COVID-19 Patients”.

cnbc.com

“WHO officials enroll first patients from Norway and Spain in 'historic' coronavirus drug trial”. CNBC. 2020년 3월 27일.

coloradosun.com

Brown J (2020년 3월 20일). “Colorado researchers are racing to find an antiviral drug that could save people with the new coronavirus”.

doi.org

dx.doi.org

Li G, De Clercq E (March 2020). “Therapeutic options for the 2019 novel coronavirus (2019-nCoV)”. 《Nature Reviews. Drug Discovery》 19 (3): 149–150. doi:10.1038/d41573-020-00016-0. PMID 32127666.
Harrison C (February 2020). “Coronavirus puts drug repurposing on the fast track”. 《Nature Biotechnology》 38 (4): 379–381. doi:10.1038/d41587-020-00003-1. PMID 32205870.
Kruse RL (2020년 1월 31일). “Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China”. 《F1000Research》 9: 72. doi:10.12688/f1000research.22211.1. PMC 7029759. PMID 32117569.
Harrison C (2020년 2월 27일). “Coronavirus puts drug repurposing on the fast track”. 《Nature Biotechnology》 38 (4): 379–381. doi:10.1038/d41587-020-00003-1. PMID 32205870.
Sleigh SH, Barton CL (2010). “Repurposing Strategies for Therapeutics”. 《Pharmaceutical Medicine》 24 (3): 151–159. doi:10.1007/BF03256811.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, 외. (March 2020). “A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19”. 《The New England Journal of Medicine》. doi:10.1056/NEJMoa2001282. PMC 7121492. PMID 32187464.
Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, 외. (March 2016). “Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys”. 《Nature》 531 (7594): 381–5. doi:10.1038/nature17180. PMC 5551389. PMID 26934220.
Lo MK, Jordan R, Arvey A, Sudhamsu J, Shrivastava-Ranjan P, Hotard AL, 외. (March 2017). “GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses”. 《Scientific Reports》 7: 43395. doi:10.1038/srep43395. PMC 5338263. PMID 28262699.
Villanueva, Paulina J.; Martinez, Alberto; Baca, Sarah T.; DeJesus, Rebecca E.; Larragoity, Manuel; Contreras, Lisett; Gutierrez, Denisse A.; Varela-Ramirez, Armando; Aguilera, Renato J. (2018년 11월 5일). “Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis”. 《PLOS ONE》 (영어) 13 (11): e0206467. doi:10.1371/journal.pone.0206467. ISSN 1932-6203. PMC 6218039. PMID 30395606. CS1 관리 - PMC 형식 (링크)
Lane, Thomas R.; Dyall, Julie; Mercer, Luke; Goodin, Caleb; Foil, Daniel H.; Zhou, Huanying; Postnikova, Elena; Liang, Janie Y.; Holbrook, Michael R. (2020년 4월 27일). “Repurposing Pyramax® for the Treatment of Ebola Virus Disease: Additivity of the Lysosomotropic Pyronaridine and Non-Lysosomotropic Artesunate”. 《bioRxiv》 (영어): 2020.04.25.061333. doi:10.1101/2020.04.25.061333.
Lane, Thomas R.; Massey, Christopher; Comer, Jason E.; Anantpadma, Manu; Freundlich, Joel S.; Davey, Robert A.; Madrid, Peter B.; Ekins, Sean (2019년 11월 21일). “Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection”. 《PLOS Neglected Tropical Diseases》 (영어) 13 (11): e0007890. doi:10.1371/journal.pntd.0007890. ISSN 1935-2735. PMC 6894882. PMID 31751347. CS1 관리 - PMC 형식 (링크)
Bae, Joon-Yong; Lee, Gee Eun; Park, Heedo; Cho, Juyoung; Kim, Yung-Eui; Lee, Joo-Yeon; Ju, Chung; Kim, Won-Ki; Kim, Jin Il (2020년 7월 28일). “Pyronaridine and artesunate are potential antiviral drugs against COVID-19 and influenza”. 《bioRxiv》 (영어): 2020.07.28.225102. doi:10.1101/2020.07.28.225102.
Krishna, Sanjeev; Augustin, Yolanda; Wang, Jigang; Xu, Chengchao; Staines, Henry M.; Platteeuw, Hans; Kamarulzaman, Adeeba; Sall, Amadou; Kremsner, Peter (2021년 1월 19일). “Repurposing Antimalarials to Tackle the COVID-19 Pandemic: (Trends in Parasitology 37, 8–11; 2021)”. 《Trends in Parasitology》 (영어) 0 (0). doi:10.1016/j.pt.2020.12.009. ISSN 1471-4922.

fda.gov

“Coronavirus (COVID-19) Update: Daily Roundup March 30, 2020”. U.S. Food and Drug Administration (FDA). 2020년 3월 30일.
“Fact Sheet for Patients and Parent/Caregivers Emergency Use Authorization (EUA) of Chloroquine Phosphate for Treatment of COVID-19 in Certain Hospitalized Patients”. U.S. Food and Drug Administration (FDA).

fox5ny.com

“NY COVID-19 cases surge; Javits Center to house temporary hospitals”. 《Fox 5》. 2020년 3월 23일.

ilfattoquotidiano.it

di Pietrobelli G (2020년 3월 22일). “Coronavirus, il Veneto sperimenta l'antivirale giapponese Favipiravir. Ma l'Aifa: "Ci sono scarse evidenze scientifiche su efficacia"”. 《Il Fatto Quotidiano》 (이탈리아어). 2020년 3월 23일에 확인함.

independent.co.uk

Gregory A (2020년 3월 18일). “Coronavirus: Japanese anti-viral drug effective in treating patients, Chinese official says”. 《The Independent》.

miamiherald.com

Gross SJ (2020년 4월 9일). “As CDC drops guidance on chloroquine as COVID-19 therapy, doctors ask for research”. 《Miami Herald》.

nature.com

Harrison C (February 2020). “Coronavirus puts drug repurposing on the fast track”. 《Nature Biotechnology》 38 (4): 379–381. doi:10.1038/d41587-020-00003-1. PMID 32205870.

nih.gov

ncbi.nlm.nih.gov

Li G, De Clercq E (March 2020). “Therapeutic options for the 2019 novel coronavirus (2019-nCoV)”. 《Nature Reviews. Drug Discovery》 19 (3): 149–150. doi:10.1038/d41573-020-00016-0. PMID 32127666.
Harrison C (February 2020). “Coronavirus puts drug repurposing on the fast track”. 《Nature Biotechnology》 38 (4): 379–381. doi:10.1038/d41587-020-00003-1. PMID 32205870.
Kruse RL (2020년 1월 31일). “Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China”. 《F1000Research》 9: 72. doi:10.12688/f1000research.22211.1. PMC 7029759. PMID 32117569.
Harrison C (2020년 2월 27일). “Coronavirus puts drug repurposing on the fast track”. 《Nature Biotechnology》 38 (4): 379–381. doi:10.1038/d41587-020-00003-1. PMID 32205870.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, 외. (March 2020). “A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19”. 《The New England Journal of Medicine》. doi:10.1056/NEJMoa2001282. PMC 7121492. PMID 32187464.
Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, 외. (March 2016). “Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys”. 《Nature》 531 (7594): 381–5. doi:10.1038/nature17180. PMC 5551389. PMID 26934220.
Lo MK, Jordan R, Arvey A, Sudhamsu J, Shrivastava-Ranjan P, Hotard AL, 외. (March 2017). “GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses”. 《Scientific Reports》 7: 43395. doi:10.1038/srep43395. PMC 5338263. PMID 28262699.
Villanueva, Paulina J.; Martinez, Alberto; Baca, Sarah T.; DeJesus, Rebecca E.; Larragoity, Manuel; Contreras, Lisett; Gutierrez, Denisse A.; Varela-Ramirez, Armando; Aguilera, Renato J. (2018년 11월 5일). “Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis”. 《PLOS ONE》 (영어) 13 (11): e0206467. doi:10.1371/journal.pone.0206467. ISSN 1932-6203. PMC 6218039. PMID 30395606. CS1 관리 - PMC 형식 (링크)
Lane, Thomas R.; Massey, Christopher; Comer, Jason E.; Anantpadma, Manu; Freundlich, Joel S.; Davey, Robert A.; Madrid, Peter B.; Ekins, Sean (2019년 11월 21일). “Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection”. 《PLOS Neglected Tropical Diseases》 (영어) 13 (11): e0007890. doi:10.1371/journal.pntd.0007890. ISSN 1935-2735. PMC 6894882. PMID 31751347. CS1 관리 - PMC 형식 (링크)

ncats.nih.gov

“Repurposing drugs”. National Center for Advancing Translational Sciences (NCATS). 2017년 11월 7일. 2020년 3월 26일에 확인함.
“Repurposing Drugs”. 《National Center for Advancing Translational Sciences (NCATS)》. U.S. Department of Health & Human Services, National Institutes of Health. 2017년 11월 7일. 2020년 3월 26일에 확인함.

plos.org

journals.plos.org

Villanueva, Paulina J.; Martinez, Alberto; Baca, Sarah T.; DeJesus, Rebecca E.; Larragoity, Manuel; Contreras, Lisett; Gutierrez, Denisse A.; Varela-Ramirez, Armando; Aguilera, Renato J. (2018년 11월 5일). “Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis”. 《PLOS ONE》 (영어) 13 (11): e0206467. doi:10.1371/journal.pone.0206467. ISSN 1932-6203. PMC 6218039. PMID 30395606. CS1 관리 - PMC 형식 (링크)
Lane, Thomas R.; Massey, Christopher; Comer, Jason E.; Anantpadma, Manu; Freundlich, Joel S.; Davey, Robert A.; Madrid, Peter B.; Ekins, Sean (2019년 11월 21일). “Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection”. 《PLOS Neglected Tropical Diseases》 (영어) 13 (11): e0007890. doi:10.1371/journal.pntd.0007890. ISSN 1935-2735. PMC 6894882. PMID 31751347. CS1 관리 - PMC 형식 (링크)

technologyreview.com

Regalado A (2020년 3월 23일). “Which Covid-19 drugs work best?”. 《MIT Technology Review》.

theguardian.com

Devlin H, Sample I (2020년 3월 19일). “What are the prospects for a COVID-19 treatment?”. 《The Guardian》.
McCurry J (2020년 3월 18일). “Japanese flu drug 'clearly effective' in treating coronavirus, says China”.

webmd.com

“Antiviral Drug Combo Ineffective Vs. Coronavirus”. 《WebMD》. 2020년 3월 20일.

who.int

WHO (2017년 6월 29일). ““Application for inclusion in the WHO Model List of essential medicines"” (PDF).

worldcat.org

Villanueva, Paulina J.; Martinez, Alberto; Baca, Sarah T.; DeJesus, Rebecca E.; Larragoity, Manuel; Contreras, Lisett; Gutierrez, Denisse A.; Varela-Ramirez, Armando; Aguilera, Renato J. (2018년 11월 5일). “Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis”. 《PLOS ONE》 (영어) 13 (11): e0206467. doi:10.1371/journal.pone.0206467. ISSN 1932-6203. PMC 6218039. PMID 30395606. CS1 관리 - PMC 형식 (링크)
Lane, Thomas R.; Massey, Christopher; Comer, Jason E.; Anantpadma, Manu; Freundlich, Joel S.; Davey, Robert A.; Madrid, Peter B.; Ekins, Sean (2019년 11월 21일). “Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection”. 《PLOS Neglected Tropical Diseases》 (영어) 13 (11): e0007890. doi:10.1371/journal.pntd.0007890. ISSN 1935-2735. PMC 6894882. PMID 31751347. CS1 관리 - PMC 형식 (링크)
Krishna, Sanjeev; Augustin, Yolanda; Wang, Jigang; Xu, Chengchao; Staines, Henry M.; Platteeuw, Hans; Kamarulzaman, Adeeba; Sall, Amadou; Kremsner, Peter (2021년 1월 19일). “Repurposing Antimalarials to Tackle the COVID-19 Pandemic: (Trends in Parasitology 37, 8–11; 2021)”. 《Trends in Parasitology》 (영어) 0 (0). doi:10.1016/j.pt.2020.12.009. ISSN 1471-4922.